X5A-26641-31417
4 vaccinations
2 coded responses
26 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 530 / WI
- Registered
- 2021-03-22
- Relationship
- Self
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-22
Registered in v-safe
-
2021-03-22
Dose 1 — Pfizer-BioNTech
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-04-05
-
2021-04-12
Dose 2 — Pfizer-BioNTech
- 2021-04-12
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-18
- 2021-04-21
-
2021-04-26
Survey response — day 14, dose 2MedDRA: Asthma — Feeling: Good · Be unable to do your normal daily activitiesFree text: AsthmaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-05
- 2021-05-10
- 2021-05-17
- 2021-05-24
- 2021-07-12
- 2021-10-11
-
2021-12-29
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-04-12
-
2022-08-08
Dose 4 — Pfizer-BioNTech
- 2022-11-09
-
2023-02-06
Survey response — 6 months, dose 4MedDRA: Bronchitis, COVID-19, Cellulitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-02-06
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-02-07
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Pfizer-BioNTech | |
| 2 | 2021-04-12 | Pfizer-BioNTech | |
| 3 | 2021-12-29 | Pfizer-BioNTech | Flu |
| 4 | 2022-08-08 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-02-06 | Successful 2023-02-07 |
Does not wish to fill out VAERS report |
Free text
Release 8 — day 14, dose 2
Symptoms: Asthma
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | ✓ | ✓ | ✓ |
| SD | Bronchitis | · | · | ✓ |
| SD | Cellulitis | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release